HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.2844
-0.0156 (-5.20%)
Mar 31, 2025, 2:29 PM EDT - Market open

HCW Biologics Statistics

Total Valuation

HCW Biologics has a market cap or net worth of $12.67 million. The enterprise value is $22.38 million.

Market Cap 12.67M
Enterprise Value 22.38M

Important Dates

The last earnings date was Friday, March 28, 2025, after market close.

Earnings Date Mar 28, 2025
Ex-Dividend Date n/a

Share Statistics

HCW Biologics has 44.54 million shares outstanding. The number of shares has increased by 3.68% in one year.

Current Share Class 44.54M
Shares Outstanding 44.54M
Shares Change (YoY) +3.68%
Shares Change (QoQ) n/a
Owned by Insiders (%) 40.57%
Owned by Institutions (%) 11.31%
Float 26.47M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.53
Forward PS 1.87
PB Ratio -1.97
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 8.72
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.19

Current Ratio 0.19
Quick Ratio 0.18
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -46.71

Financial Efficiency

Return on equity (ROE) is -897.37% and return on invested capital (ROIC) is -137.31%.

Return on Equity (ROE) -897.37%
Return on Assets (ROA) -62.72%
Return on Invested Capital (ROIC) -137.31%
Return on Capital Employed (ROCE) -4,851.08%
Revenue Per Employee $57,040
Profits Per Employee -$667,196
Employee Count 45
Asset Turnover 0.09
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -82.95% in the last 52 weeks. The beta is 0.80, so HCW Biologics's price volatility has been lower than the market average.

Beta (5Y) 0.80
52-Week Price Change -82.95%
50-Day Moving Average 0.36
200-Day Moving Average 0.50
Relative Strength Index (RSI) 36.50
Average Volume (20 Days) 113,763

Short Selling Information

The latest short interest is 450,173, so 1.01% of the outstanding shares have been sold short.

Short Interest 450,173
Short Previous Month 543,708
Short % of Shares Out 1.01%
Short % of Float 1.70%
Short Ratio (days to cover) 0.28

Income Statement

In the last 12 months, HCW Biologics had revenue of $2.57 million and -$30.02 million in losses. Loss per share was -$0.77.

Revenue 2.57M
Gross Profit 959,403
Operating Income -29.48M
Pretax Income -27.39M
Net Income -30.02M
EBITDA -28.30M
EBIT -29.48M
Loss Per Share -$0.77
Full Income Statement

Balance Sheet

The company has $4.67 million in cash and $13.69 million in debt, giving a net cash position of -$9.02 million or -$0.20 per share.

Cash & Cash Equivalents 4.67M
Total Debt 13.69M
Net Cash -9.02M
Net Cash Per Share -$0.20
Equity (Book Value) -6.77M
Book Value Per Share -0.15
Working Capital -23.93M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.23 million and capital expenditures -$261,617, giving a free cash flow of -$19.15 million.

Operating Cash Flow -14.23M
Capital Expenditures -261,617
Free Cash Flow -19.15M
FCF Per Share -$0.43
Full Cash Flow Statement

Margins

Gross Margin 37.38%
Operating Margin -1,148.50%
Pretax Margin -1,169.70%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HCW Biologics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.68%
Shareholder Yield n/a
Earnings Yield -224.69%
FCF Yield -143.32%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) 125.94%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3